XML 21 R41.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Commitments and Contingencies (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 02, 2018
Nov. 27, 2019
Aug. 22, 2017
Dec. 31, 2011
Oct. 31, 2019
Jul. 31, 2019
Nov. 16, 2012
Sep. 30, 2019
Aug. 31, 2019
May 31, 2019
Apr. 30, 2019
Feb. 28, 2019
Jan. 24, 2019
Nov. 25, 2018
Oct. 26, 2018
Jul. 31, 2018
Commitments and Contingencies     The letter from AEXG counsel claimed that Generex’s acceptance of $3,000,000 in financing from Pharma Trials, LLC, in March 2017, violated the provisions of the MOU prohibiting Generex from seeking other financing, with certain exceptions, for a period of 60 days after execution of the MOU. AEXG has demanded at least $210,000 in cash and 84,000 warrants for Generex stock convertible at $2.50 per share, for attorney’s fees and costs.                          
Rental Payment, 2020         $ 39,879                     $ 112,801
Rental payment, 2021         0                     $ 39,879
Litigation awards for damages $ 315,695                              
Litigation awards, exercisable shares 84,000                              
Exercise price $ 2.50                              
Note amount           $ 446,600   $ 2,222,500 $ 1,150,000 $ 2,000,000 $ 1,060,000 $ 1,500,000 $ 530,000 $ 1,060,000 $ 682,000  
Value of the warrants         65,613 232,283                    
Liquidated damages         220,000 220,000                    
Accrued Liquidated damages         285,613 452,283                    
Accrued claim         $ 2,752,235 $ 2,752,235                    
Alternative Execution Group [Member]                                
Memorandum of Understanding description The petition includes a demand of $3,300,360 as the value of the Warrants. The arbitrator did not award the specific amount of $3.3 million, but only liquidated damages in the amount of $220,000 and the value of 84,000 warrants “as of today” (the date of the award) plus attorney’s fees, certain costs, prejudgment and post-judgment interest (which continues to run on a daily basis) and arbitration fees.                              
Olaregen                                
Intellectual property acquired   $ 650,000                            
Damages for Unpaid Invoices                                
Value of damages sought       $ 429,000                        
Lawsuit filing date       31-Dec-11                        
Name of Plaintiff       Vendor                        
Settlement of litigation             $ 125,000                  
Interest per annum, failure to pay settlement       3.00%                        
Fixed cost per annum, failure to pay settlement       $ 25,000                        
Breach of contract and detinue                                
Counterclaim proceeding       $ 200,000